0.3155
price up icon0.25%   0.0045
 
loading
전일 마감가:
$0.32
열려 있는:
$0.3104
하루 거래량:
872.01K
Relative Volume:
0.28
시가총액:
$28.89M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
-0.1077
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
+12.05%
1개월 성능:
-6.36%
6개월 성능:
+4.16%
1년 성능:
-68.55%
1일 변동 폭
Value
$0.3064
$0.3316
1주일 범위
Value
$0.2806
$0.3316
52주 변동 폭
Value
$0.18
$1.74

Fibrogen Inc Stock (FGEN) Company Profile

Name
명칭
Fibrogen Inc
Name
전화
415-978-1200
Name
주소
350 BAY STREET, SAN FRANCISCO, CA
Name
직원
225
Name
트위터
@FibroGenInc
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
FGEN's Discussions on Twitter

FGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FGEN
Fibrogen Inc
0.3136 28.89M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.41 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
599.66 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
613.49 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.80 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.92 24.89B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-08 다운그레이드 BofA Securities Neutral → Underperform
2023-06-26 다운그레이드 BofA Securities Buy → Neutral
2023-06-26 다운그레이드 Raymond James Outperform → Mkt Perform
2023-06-26 다운그레이드 Stifel Buy → Hold
2023-06-26 다운그레이드 William Blair Outperform → Mkt Perform
2023-06-02 업그레이드 Stifel Hold → Buy
2023-01-31 업그레이드 William Blair Mkt Perform → Outperform
2023-01-26 업그레이드 Raymond James Mkt Perform → Outperform
2023-01-05 업그레이드 BofA Securities Neutral → Buy
2021-09-22 다운그레이드 Goldman Neutral → Sell
2021-08-20 업그레이드 Raymond James Underperform → Mkt Perform
2021-07-16 다운그레이드 BofA Securities Buy → Neutral
2021-07-16 다운그레이드 Stifel Buy → Hold
2021-04-07 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-07 다운그레이드 Mizuho Buy → Neutral
2021-03-31 업그레이드 BofA Securities Neutral → Buy
2021-03-02 다운그레이드 Jefferies Buy → Hold
2021-02-01 개시 H.C. Wainwright Buy
2020-10-26 개시 Raymond James Underperform
2020-07-10 재개 Stifel Buy
2020-05-01 개시 Cowen Market Perform
2020-04-27 개시 BofA/Merrill Neutral
2019-05-29 재개 Goldman Neutral
2019-05-10 다운그레이드 William Blair Outperform → Mkt Perform
2019-04-12 개시 Piper Jaffray Neutral
2019-02-11 재개 Stifel Buy
2018-12-19 업그레이드 Citigroup Neutral → Buy
2017-08-08 재확인 Leerink Partners Outperform
2017-08-08 재확인 Stifel Buy
2017-07-21 다운그레이드 Goldman Buy → Neutral
2017-07-11 개시 Jefferies Buy
2016-02-11 업그레이드 Credit Suisse Neutral → Outperform
2016-01-21 개시 Credit Suisse Neutral
2015-12-04 개시 Citigroup Buy
2015-09-23 개시 Lake Street Hold
2015-07-29 개시 Citigroup Buy
2015-07-20 업그레이드 Goldman Neutral → Buy
2014-12-09 개시 Stifel Buy
모두보기

Fibrogen Inc 주식(FGEN)의 최신 뉴스

pulisher
Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025
pulisher
Apr 11, 2025

FGEN Stock Price and Chart — NASDAQ:FGEN - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

Investors Don't See Light At End Of FibroGen, Inc.'s (NASDAQ:FGEN) Tunnel And Push Stock Down 26% - simplywall.st

Apr 08, 2025
pulisher
Apr 02, 2025

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Apr 02, 2025
pulisher
Apr 01, 2025

William Blair Keeps Their Hold Rating on FibroGen (FGEN) - The Globe and Mail

Apr 01, 2025
pulisher
Mar 30, 2025

FibroGen extends merger option deadline with Fortis - Investing.com Australia

Mar 30, 2025
pulisher
Mar 28, 2025

FibroGen extends merger option deadline with Fortis By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Morgan Stanley’s Adam Jonas Is Pounding the Table on This 1 ‘Unique’ Stock - The Globe and Mail

Mar 28, 2025
pulisher
Mar 28, 2025

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

FibroGen reports promising FG-3246 study results for prostate cancer - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

1 Top Cryptocurrency to Buy Before It Soars 14,623%, According to Michael Saylor - The Globe and Mail

Mar 27, 2025
pulisher
Mar 25, 2025

Fibrogen CEO Wettig Thane buys $50,663 in common stock By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Fibrogen CEO Wettig Thane buys $50,663 in common stock - Investing.com India

Mar 25, 2025
pulisher
Mar 24, 2025

Fibrogen director James Schoeneck buys $105,040 in stock By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 20, 2025

In the Red? AstraZeneca Acquires FibroGen, Inc.’s China Subsidiary - Law Street Media

Mar 20, 2025
pulisher
Mar 19, 2025

FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

FibroGen Full Year 2024 Earnings: Beats Expectations - Yahoo

Mar 19, 2025
pulisher
Mar 18, 2025

FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... By GuruFocus - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with Strategic Initiatives - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

FibroGen Announces Strategic Sale and Financial Outlook - TipRanks

Mar 18, 2025
pulisher
Mar 17, 2025

FibroGen: Q4 Earnings Snapshot - mySA

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings call transcript: FibroGen reports Q4 2024 EPS beat, stock dips - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings call transcript: FibroGen reports Q4 2024 EPS beat, stock dips By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen Inc earnings beat by $0.35, revenue fell short of estimates - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen Inc Reports Q4 2024 Earnings: EPS Loss of $0.08 Beats E - GuruFocus

Mar 17, 2025
pulisher
Mar 17, 2025

FIBROGEN Earnings Results: $FGEN Reports Quarterly Earnings - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

FIBROGEN INC SEC 10-K Report - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen, Inc. Announces Sale of FibroGen China to AstraZeneca for $160 Million and Updates on Clinical Trials - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

FibroGen's Strategic $160M China Exit Extends Cash Runway to 2027 Amid Latest Earnings - StockTitan

Mar 17, 2025
pulisher
Mar 15, 2025

FIBROGEN Earnings Preview: Recent $FGEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 14, 2025

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Weekly CEO Buys Highlight: Camping World, FibroGen - GuruFocus.com

Mar 12, 2025
pulisher
Mar 10, 2025

AstraZeneca’s $160 Million Acquisition of FibroGen China - Global Legal Chronicle

Mar 10, 2025
pulisher
Mar 06, 2025

Ropes & Gray Advises FibroGen in $160 Million Sale of Fibrogen China to AstraZeneca - Ropes & Gray LLP

Mar 06, 2025
pulisher
Mar 03, 2025

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

FibroGen, Inc. to Announce Q4 and Full Year 2024 Financial Results on March 17 - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

When Will FibroGen Reveal Its 2024 Performance? Key Date for Investors Announced - StockTitan

Mar 03, 2025

Fibrogen Inc (FGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fibrogen Inc 주식 (FGEN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
Adib Deyaa
Chief Medical Officer
Jun 12 '24
Buy
1.17
22,123
25,884
82,123
$20.39
price down icon 0.63%
$68.60
price down icon 0.25%
$32.01
price down icon 0.09%
$34.64
price down icon 7.28%
$114.80
price down icon 4.57%
biotechnology ONC
$248.25
price down icon 2.59%
자본화:     |  볼륨(24시간):